Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China · Delayed Price · Currency is CNY 68.37
-1.51 (-2.16%)
Aug 11, 2026, 2:25 PM CST
Betta Pharmaceuticals Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,732 | 3,609 | 2,892 | 2,456 | 2,377 | 2,246 |
Revenue Growth | 21.40% | 24.81% | 17.74% | 3.35% | 5.82% | 20.08% |
Gross Profit Gross Profit Growth | 2,947 | 2,871 | 2,353 | 2,052 | 2,108 | 2,071 |
Operating Income Operating Income Growth | 613.18 | 540.45 | 476.96 | 279.88 | 206.96 | 348.77 |
Net Income Net Income Growth | 441.16 | 305.33 | 402.57 | 348.03 | 145.42 | 383.07 |
Earnings Per Share EPS Growth | 1.05 | 0.73 | 0.96 | 0.83 | 0.35 | 0.92 |
EPS Growth | 8.43% | -23.96% | 15.66% | 137.47% | -62.01% | -38.26% |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
China China Growth | 3,589 | 2,856 |
Foreign Foreign Growth | 20.78 | 35.64 |
Total Total Growth | 3,609 | 2,892 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 510.23 | 495.98 | 598.12 | 752.54 | 731.28 | 993 |
Total Debt Total Debt Growth | 2,561 | 2,462 | 2,396 | 2,430 | 1,048 | 11.22 |
Net Cash (Debt) Net Cash Growth | -2,051 | -1,966 | -1,798 | -1,678 | -316.59 | 981.77 |
Net Cash Growth | - | - | - | - | - | -35.97% |
Net Cash Per Share Net Cash Per Share Growth | -4.89 | -4.70 | -4.29 | -4.00 | -0.76 | 2.36 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 877.33 | 911.26 | 911.17 | 914.23 | 306.74 | 526.63 |
Capital Expenditures CapEx Growth | -775.77 | -616.68 | -827.59 | -1,096 | -1,011 | -758.38 |
Free Cash Flow Free Cash Flow Growth | 101.57 | 294.58 | 83.58 | -181.79 | -703.8 | -231.75 |
Free Cash Flow Growth | -60.14% | 252.46% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 78.98% | 79.53% | 81.38% | 83.53% | 88.69% | 92.23% |
Operating Margin | 16.43% | 14.97% | 16.49% | 11.39% | 8.71% | 15.53% |
Pretax Margin | 15.37% | 11.48% | 13.63% | 13.11% | 3.68% | 17.36% |
Profit Margin | 11.82% | 8.46% | 13.92% | 14.17% | 6.12% | 17.06% |
FCF Margin | 2.72% | 8.16% | 2.89% | -7.40% | -29.61% | -10.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.150 | 0.200 | 0.170 | 0.070 | 0.250 |
Dividend Per Share Growth | -24.60% | -25.00% | 17.65% | 142.86% | -72.00% | -19.36% |
Dividend Yield | 0.21% | 0.32% | 0.37% | 0.33% | 0.14% | 0.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 66.42 | 64.34 | 56.06 | 61.99 | 141.14 | 86.55 |
Forward PE | 37.37 | 26.59 | 29.63 | 42.25 | 65.91 | 49.20 |
P/FCF Ratio | 289.48 | 66.69 | 270.04 | - | - | - |
PS Ratio | 7.88 | 5.44 | 7.80 | 8.78 | 8.64 | 14.76 |